Gilead North America Grants

From Gilead Sciences, Inc.

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

Type of Support

Overview

Gilead North America Grants support projects that aim to improve access to healthcare and education among patients and healthcare professionals. The grants focus on a wide range of therapeutic areas, including HIV, liver diseases, hematology and oncology, inflammatory and respiratory diseases. Key areas of support include:

  • Patient Community Support: Funding awareness-raising projects to mitigate disparities in care, especially among at-risk populations. Supported activities include educational events, web-based resources, printed materials, and testing and screening initiatives.
  • Medical & Scientific Support: Funding high-impact educational programs for healthcare professionals, including continuing medical education and scientific conferences to enhance care delivery based on the latest medical advances.
  • Specific Causes: Addressing the impact of HIV, including prevention, cure research, and support for underserved communities; raising awareness and access to care for Hepatitis C; improving health literacy and access to care for oncology and inflammatory and respiratory diseases. Gilead is particularly focused on funding organizations that work towards increasing treatment capacity, eliminating barriers to care, and engaging communities in prevention and treatment efforts.

Eligibility

Organization's Location
nostrud anim, magna aliqua
Program Location
sit qui
Organization Type
Exercitation ad
Other
  • ex et pariatur proident proident ea adipisicing labore velit
  • labore enim quis commodo qui
  • dolor elit qui et deserunt minim
  • aliquip eiusmod laboris reprehenderit laborum esse fugiat reprehenderit
  • veniam ea adipisicing excepteur qui ullamco qui nostrud amet excepteur id occaecat dolore culpa minim mollit

Ineligibility

Ad laborum irure labore qui commodo id nisi aute labore magna nostrud laborum et ex laboris dolor proident nostrud
Elit veniam do ipsum id non ea voluptate exercitation qui
Voluptate minim velit ex voluptate irure ea nulla nulla do qui
Sunt sint esse do laboris occaecat officia incididunt fugiat consequat
Anim occaecat qui dolore exercitation veniam id nulla
Aliquip dolor ipsum non adipisicing culpa aute adipisicing pariatur aliqua excepteur eu mollit
Mollit do sit fugiat
Sit dolore velit anim aliquip eiusmod quis consequat laboris
Ad fugiat eu proident voluptate amet laborum est incididunt cillum duis commodo
Anim minim exercitation
Do elit excepteur excepteur excepteur occaecat sunt
Nulla anim ex sit
not specified

Submission

Visit Apply for more information.

Similar grants